Simian immunodeficiency virus-specific cytotoxic T lymphocytes and protection against challenge in rhesus macaques immunized with a live attenuated simian immunodeficiency virus vaccine

Virology

Volumn 266, Issue 1, 2000, Pages 203-210

  Nixon, Douglas F ^a   Donahoe, Sean M ^a   Kakimoto, William M ^a   Samuel, Rachel V ^b   Metzner, Karin J ^a   Gettie, Agegnehu ^a,c   Hanke, Tomas ^b   Marx, Preston A ^a,c   Connor, Ruth I ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c TULANE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SIMIAN IMMUNODEFICIENCY VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; IMMUNE RESPONSE; LONGITUDINAL STUDY; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION; VIRUS INFECTION;

ANIMALIA; MACACA; MACACA MULATTA; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0034606709     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.0078     Document Type: Article

References (48)

1. Allen T. M., Sidney J., del Guercio M. F., Glickman R. L., Lensmeyer G. L., Wiebe D. A., DeMars R., Pauza C. D., Johnson R. P., Sette A., Watkins D. I. Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus. J. Immunol. 160:1998;6062-6071.
2. Almond N., Rose J., Sangster R., Silvera P., Stebbings R., Walker B., Stott E. J. Mechanisms of protection induced by attenuated simian immunodeficiency virus. I. Protection cannot be transferred with immune serum. J. Gen. Virol. 78:1997;1919-1922.
3. Altman J. D., Moss P. A. H., Golder P. J. R., Barouch D. H., McHeyzer-Williams M. G., Bell J. I., McMichael A. J., Davis M. M. Phenotypic analysis of antigen-specific T lymphocytes. Science. 274:1996;94-96.
4. Baumgarth N., Herman O. C., Jager G. C., Brown L., Herzenberg L. A. Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system. Proc. Natl. Acad. Sci. USA. 96:1999;2250-2255.
5. Beer B., Baier M., zur Megede J., Norley S., Kurth R. Vaccine effect using a live attenuated nef-deficient simian immunodeficiency virus of African green monkeys in the absence of detectable vaccine virus replication in vivo. Proc. Natl. Acad. Sci. USA. 94:1997;4062-4067.
6. Busch D. H., Pamer E. G. T cell affinity maturation by selective expansion during infection [In Process Citation]. J. Exp. Med. 189:1999;701-710.
7. Connor R., Montefiori D., Binley J., Moore J., Bonhoeffer S., Gettie A., Fenamore E., Sheridan K., Ho D., Dailey P., Marx P. Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine. J. Virol. 72:1998;7501-7509.
8. Desrosiers R. Prospects for live attenuated HIV. Nat. Med. 4:1998;982.
9. Desrosiers R. C. HIV with multiple gene deletions as a live attenuated vaccine for AIDS. AIDS Res. Hum. Retroviruses. 8:1992;411-421.
10. Desrosiers R. C., Lifson J. D., Gibbs J. S., Czajak S. C., Howe A. Y., Arthur L. O., Johnson R. P. Identification of highly attenuated mutants of simian immunodeficiency virus. J. Virol. 72:1998;1431-1437.
11. Dittmer U., Nisslein T., Bodemer W., Petry H., Sauermann U., Stahl-Hennig C., Hunsmann G. Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus. Virology. 212:1995;392-397.
12. Evans D. T., Piekarczyk M. S., Allen T. M., Boyson J. E., Yeager M., Hughes A. L., Gotch F. M., Hinshaw V. S., Watkins D. I. Immunodominance of a single CTL epitope in a primate species with limited MHC class I polymorphism. J. Immunol. 159:1997;1374-1382.
13. Farthing C., Sullivan J. SIV vaccine for AIDS. Science. 279:1998;14-15.
14. Fowke K. R., Nagelkerke N. J., Kimani J., Simonsen J. N., Anzala A. O., Bwayo J. J., MacDonald K. S., Ngugi E. N., Plummer F. A. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya [see comments]. Lancet. 348:1996;1347-1351.
15. + nef-specific cytotoxic T cells in vaccinated macaques. Nat. Med. 1:1995;1167-1173.
16. Gallimore A., Glithero A., Godkin A., Tissot A. C., Pluckthun A., Elliott T., Hengartner H., Zinkernagel R. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J. Exp. Med. 187:1998;1383-1393.
17. Gauduin M. C., Glickman R. L., Means R., Johnson R. P. Inhibition of simian immunodeficiency virus (SIV) replication by CD8(+) T lymphocytes from macaques immunized with live attenuated SIV. J. Virol. 72:1998;6315-6324.
18. Guidotti L. G., Rochford R., Chung J., Shapiro M., Purcell R., Chisari F. V. Viral clearance without destruction of infected cells during acute HBV infection [In Process Citation]. Science. 284:1999;825-829.
19. Gundlach B. R., Reiprich S., Sopper S., Means R. E., Dittmer U., Matz-Rensing K., Stahl-Hennig C., Uberla K. Env-independent protection induced by live, attenuated simian immunodeficiency virus vaccines. J. Virol. 72:1998;7846-7851.
20. Hanke T., Neumann V. C., Blanchard T. J., Sweeney P., Hill A. V., Smith G. L., McMichael A. Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime. Vaccine. 17:1999;589-596.
21. Hulskotte E. G., Geretti A. M., Siebelink K. H., van Amerongen G., Cranage M. P., Rud E. W., Norley S. G., de Vries P., Osterhaus A. D. Vaccine-induced virus-neutralizing antibodies and cytotoxic T cells do not protect macaques from experimental infection with simian immunodeficiency virus SIVmac32H (J5). J. Virol. 69:1995;6289-6296.
22. Johnson R. P., Glickman R. L., Yang J. Q., Kaur A., Dion J. T., Mulligan M. J., Desrosiers R. C. Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus. J. Virol. 71:1997;7711-7718.
23. Johnson R. P., Lifson J. D., Czajak S. C., Cole K. S., Manson K. H., Glickman R., Yang J., Montefiori D. C., Montelaro R., Wyand M. S., Desrosiers R. C. Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: inverse relationship of degree of protection with level of attenuation [In Process Citation]. J. Virol. 73:1999;4952-4961.
24. Kakimoto W. M., Gettie A., Smith S., Donahoe S. M., Jin X., Marx P., Connor R., Nixon D. F. Comparison of restimulation methods to elicit SIV specific cytotoxic T- lymphocytes (CTL) in vitro: Staphylococcal enterotoxin B (SEB) provides a novel method for the quantification of SIV specific CTL precursors [In Process Citation]. Immunol. Lett. 66:1999;135-140.
25. + T cells in macaques protected from SIV challenge by prior SIV subunit vaccination. J. Virol. 70:1996;4941-4947.
26. Koup R. A., Safrit J. T., Cao Y., Andrews C. A., McLeod G., Borkowsky W., Farthing C., Ho D. D. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:1994;4650-4655.
27. Kuroda M., Schmitz J., Barouch D., Craiu A., Allen T., Sette A., Watkins D., Forman M., Letvin N. Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex. J. Exp. Med. 187:1998;1373-1381.
28. Kuroda M., Schmitz J., Charini W., Nickerson C., Lord C., Forman M., Letvin N. Comparative analysis of cytotoxic T lymphocytes in lymph nodes and peripheral blood of simian immunodeficiency virus-infected rhesus monkeys. J. Virol. 73:1999a;1573-1579.
29. Kuroda M. J., Schmitz J. E., Charini W. A., Nickerson C. E., Lifton M. A., Lord C. I., Forman M. A., Letvin N. L. Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys [In Process Citation]. J. Immunol. 162:1999b;5127-5133.
30. Langlois A. J., Desrosiers R. C., Lewis M. G., Kewal-Ramani V. N., Littman D. R., Zhou J. Y., Manson K., Wyand M. S., Bolognesi D. P., Montefiori D. C. Neutralizing antibodies in sera from macaques immunized with attenuated simian immunodeficiency virus. J. Virol. 72:1998;6950-6955.
31. Lohman B. L., McChesney M. B., Miller C. J., McGowan E., Joye S. M., Van Rompay K. K., Reay E., Antipa L., Pedersen N. C., Marthas M. L. A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge. J. Virol. 68:1994a;7021-7029.
32. Lohman B. L., McChesney M. B., Miller C. J., Otsyula M., Berardi C. J., Marthas M. L. Mucosal immunization with a live, virulence-attenuated simian immunodeficiency virus (SIV) vaccine elicits antiviral cytotoxic T lymphocytes and antibodies in rhesus macaques. J. Med. Primatol. 23:1994b;95-101.
33. Miller M. D., Yamamoto H., Hughes A. L., Watkins D. I., Letvin N. L. Definition of an epitope and MHC class I molecule recognized by gag-specific cytotoxic T lymphocytes in SIVmac-infected rhesus monkeys. J. Immunol. 147:1991;320-329.
34. Nilsson C., Makitalo B., Thorstensson R., Norley S., Binninger-Schinzel D., Cranage M., Rud E., Biberfeld G., Putkonen P. Live attenuated simian immunodeficiency virus (SIV)mac in macaques can induce protection against mucosal infection with SIVsm. AIDS. 12:1998;2261-2270.
35. Norley S., Beer B., Binninger-Schinzel D., Cosma C., Kurth R. Protection from pathogenic SIVmac challenge following short-term infection with a nef-deficient attenuated virus. Virology. 219:1996;195-205.
36. Ogg G. S., Jin X., Bonhoeffer S., Moss P., Nowak M. A., Monard S., Segal J. P., Cao Y., Rowland-Jones S. L., Hurley A., Markowitz M., Ho D. D., McMichael A. J., Nixon D. F. Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J. Virol. 73:1999;797-800.
37. Rowland-Jones S., Dong T., Fowke K., Kimani J., Krausa P., Newell H., Blanchard T., Ariyoshi K., Oyugi J., Ngugi E., Bwayo J., MacDonald K., McMichael A., Plummer F. Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J. Clin. Invest. 102:1998;1758-1765.
38. Rowland-Jones S., Sutton J., Ariyoshi K., Dong T., Gotch F., McAdam S., Whitby D., Sabally S., Gallimore A., Corrah T. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women [published erratum appears in Nat. Med. (1995). 1, 598]. Nat. Med. 1:1995;59-64.
39. + lymphocytes. Science. 283:1999;857-860.
40. Selin L. K., Varga S. M., Wong I. C., Welsh R. M. Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations. J. Exp. Med. 188:1998;1705-1715.
41. Shibata R., Siemon C., Czajak S. C., Desrosiers R. C., Martin M. A. Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus. J. Virol. 71:1997;8141-8148.
42. Sodora D. L., Sheridan K. E., Marx P. A., Connor R. I. Immunization with a live, attenuated simian immunodeficiency virus vaccine leads to restriction of viral diversity in rhesus macaques not protected from pathogenic challenge. J. Virol. 73:1999;4443-4446.
43. Stebbings R., Stott J., Almond N., Hull R., Lines J., Silvera P., Sangster R., Corcoran T., Rose J., Cobbold S., Gotch F., McMichael A., Walker B. Mechanisms of protection induced by attenuated simian immunodeficiency virus. II. Lymphocyte depletion does not abrogate protection. AIDS Res. Hum. Retroviruses. 14:1998;1187-1198.
44. Titti F., Sernicola L., Geraci A., Panzini G., Di Fabio S., Belli R., Monardo F., Borsetti A., Maggiorella M. T., Koanga-Mogtomo M., Corrias F., Zamarchi R., Amadori A., Chieco-Bianchi L., Verani P. Live attenuated simian immunodeficiency virus prevents super-infection by cloned SIVmac251 in cynomolgus monkeys. J. Gen. Virol. 78:1997;2529-2539.
45. Wyand M. S., Manson K. H., Lackner A. A., Desrosiers R. C. Resistance of neonatal monkeys to live attenuated vaccine strains of simian immunodeficiency virus [see comments]. Nat. Med. 3:1997;32-36.
46. Wyand M. S., Manson K. H., Miller C. J., Neurath A. R. Effect of 3-hydroxyphthaloyl-beta-lactoglobulin on vaginal transmission of simian immunodeficiency virus in rhesus monkeys [In Process Citation]. Antimicrob. Agents Chemother. 43:1999;978-980.
47. + lymphocyte response in acutely infected rhesus monkeys. J. Virol. 67:1993;1707-1711.
48. Yasutomi Y. K., Woods R. M., Madsen J., Wassef N. M., Alving C. R., Klein H., Nolan T. E., Boots L. J., Kessler J. A., Emini E. A., Conley A. J., Letvin N. L. A vaccine-elicited, single viral epitope-specific cytotoxic T lymphocyte response does not protect against intravenous, cell-free simian immunodeficiency virus challenge. J. Virol. 69:1995;2279-2284.